The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ping AN Healthcare and Technology Co Ltd
HKEX:1833
|
CN |
|
Option Care Health Inc
NASDAQ:OPCH
|
US |
|
Cranswick PLC
LSE:CWK
|
UK |
|
Eni SpA
MIL:ENI
|
IT |
|
G
|
Genix Pharmaceuticals Corp
OTC:GENPF
|
CA |
|
N
|
Nippon Television Holdings Inc
XMUN:NP9
|
JP |
|
E
|
Entravision Communications Corp
F:EV9
|
US |
|
P
|
Pepkor Holdings Ltd
JSE:PPH
|
ZA |
|
Freelancer Ltd
ASX:FLN
|
AU |
|
G
|
Gridwiz Co Ltd
KOSDAQ:453450
|
KR |
|
Haier Smart Home Co Ltd
F:HAI0
|
CN |
|
C
|
Chorus Ltd
OTC:CHRUF
|
NZ |
|
D
|
Dongwon Systems Corp
KRX:014825
|
KR |
|
L
|
Legion Consortium Ltd
HKEX:2129
|
SG |
|
Hazer Group Ltd
ASX:HZR
|
AU |
|
Leonteq AG
F:EFL
|
CH |
|
W
|
Wooyang Co Ltd
KOSDAQ:103840
|
KR |
|
HUTCHMED (China) Ltd
LSE:HCM
|
HK |
|
M
|
Manulife Financial Corp
NYSE:MFC
|
CA |
Ping AN Healthcare and Technology Co Ltd (1833)’s 12-month stock price forecast through October 2027 has a consensus target of HK$10.91, implying 104% upside. The forecast is based on price targets from 15 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
Ping AN Healthcare and Technology Co Ltd is 10.91 HKD with a low forecast of 6.87 HKD and a high forecast of 14.7 HKD.
Over the last 9 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 11%.
Over the last 9 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 8 years is 11%.
The compound annual growth rate for Operating Income over the next 8 years is 40%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 17%.
The compound annual growth rate for Net Income over the next 8 years is 16%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more